Evidence map›Paper›PMID 9117306›Full record

Trial reportThe British journal of surgery1997

Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of Cancer.

J P Arnaud, B Nordlinger, J F Bosset, G H Boes, T Sahmoud, P M Schlag, F Pene

Open access · greenAbstract readClinical TrialClinical Trial, Phase IIIMulticenter Study
In one paragraph

Trial report in The British journal of surgery, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2013
    Article
  5. [Therapy of locally recurrent rectal carcinoma].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2009
    Review
  6. [Problems in the treatment of upper rectal carcinoma].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2008
    Article
  7. Article
  8. Article
  9. [Locally recurrent rectal carcinoma].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2004
    Article
  10. [Adjuvant and neoadjuvant therapy of rectal carcinoma. The current status].Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 1998
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

J P ArnaudDepartment of Visceral Surgery, Centre Hospitalo-Universitaire, Angers, France.
B Nordlinger
J F Bosset
G H Boes
T Sahmoud
P M Schlag
F Pene
European Organisation for Research and Treatment of Cancer · BESorbonne Université · FRCentre Hospitalier Universitaire d'Angers · FRCentre Hospitalier Universitaire de Besançon · FR

Funding

EORTC HEADQUARTERSU10CA011488 · NCI · EUROPEAN ORG/RES/TREATMENT/CANCER · PI LACOMBE, DENIS · 1985 to 2015
$6.6M
NCI NIH HHS 2U1O-CA11488-25NCI NIH HHS 5R10-CA11488-12
6 · The paper itself

Abstract

backgroundThere is controversy whether adjuvant radiotherapy should be given before or after surgery for locally advanced, resectable rectal cancer. Preoperative radiotherapy substantially reduces local recurrence rates but may increase postoperative complications. In addition, patients found to have early cancers are treated unnecessarily. This study is a randomized trial of postoperative radiotherapy in patients who had a potentially curative resection for locally advanced rectal carcinoma.

methodsFollowing complete excision of a Dukes B or C rectal cancer, 172 patients were randomized to adjuvant radiotherapy (46 Gy 5 days per week in 30-38 days) (84 patients) or controls (88 patients).

resultsAfter a median follow-up of 85 months, no benefit from postoperative radiotherapy had been observed in disease-free survival (P = 0.81), overall survival (P = 0.52), local recurrence-free interval (P = 0.46) or in the number and sites of recurrence. Acute toxicity following radiotherapy included diarrhoea (20 per cent), cystitis (13 per cent), delayed wound healing (7 per cent), pneumonia (5 per cent) and seizures (1 per cent). Late complications included reoperation for small bowel obstruction (5 per cent), chronic diarrhoea (20 per cent), chronic cystitis (12 per cent) and persistent perineal sinus (9 per cent). In the group who had surgery alone, late morbidity was found in 11 per cent.

conclusionThis trial failed to demonstrate any improvement in overall survival or local control when postoperative irradiation was given following resection of locally advanced rectal carcinoma.

Indexed as

AdultAgedCohort StudiesCombined Modality TherapyDisease-Free SurvivalFemaleHumansMaleMiddle AgedNeoplasm Recurrence, LocalPatient CompliancePostoperative ComplicationsRadiotherapyRectal NeoplasmsSurvival RateTreatment Outcome

Identifiers

PMID9117306
PMCPMC11440828
OpenAlexW2009016003

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.